Marijuana News & Analysis
3 articles
Market Mood
Canopy Growth (CGC) Analyst Target at $1.22 Indicates 27% Upside
Canopy Growth (CGC) recently dropped below $1 per share despite a previous surge during the spring marijuana rally. The average analyst price target is currently $1.22, representing a potential 27% increase from its current trading price. Roth Capital Partners analyst Bill Kirk has set a more optimistic price target of 5 Canadian dollars, indicating a possible fourfold increase. However, Kirk's estimates for FY2027 project a modest 5.1% revenue growth, and adjusted EBITDA is expected to remain near breakeven, suggesting that significant gains may be challenging without favorable regulatory changes.
Read More: Canopy Growth (CGC) Analyst Target at $1.22 Indicates 27% Upside
White House Marijuana Controls Easing Expected Soon
The U.S. Department of Justice (DOJ) is expected to ease marijuana controls as soon as Wednesday. This follows news that President Trump may soon reclassify marijuana to a safer drug category. The reclassification could have significant implications for cannabis companies and the broader market. Analysts are evaluating the potential effects on trading volumes and stock prices of cannabis-related firms.
Read More: White House Marijuana Controls Easing Expected Soon
Trump to reclassify marijuana controls as early as Wednesday
The U.S. is expected to move to reclassify marijuana as soon as Wednesday, with reports indicating that the Department of Justice (DOJ) is set to ease restrictions. This potential reclassification is significant as it may alter legal status and economic engagement surrounding marijuana. Market participants are closely monitoring developments due to the implications for a growing industry valued at billions. Key stakeholders, including businesses and investors in the cannabis sector, stand to be impacted should the reclassification proceed as forecasted.
Read More: Trump to reclassify marijuana controls as early as Wednesday